C9016 – Injection, triptorelin extended release, 3.75 mg

Long description

Injection, triptorelin extended release, 3.75 mg

Short description

Inj, triptorelin ext rel

Pricing indicator

53 Statute

Medicare coverage

D Special coverage instructions apply

BETOS category

O1E Other drugs

Cross reference

J3316

Added

January 1, 2018

Last change

January 1, 2019 – No change

Termination date

December 31, 2018

Nearby C codes

• C8933 – Magnetic resonance angiography without contrast followed by with contrast, spinal canal and contents
• C8934 – Magnetic resonance angiography with contrast, upper extremity
• C8935 – Magnetic resonance angiography without contrast, upper extremity
• C8936 – Magnetic resonance angiography without contrast followed by with contrast, upper extremity
• C8937 – Computer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician review for interpretation (list separately in addition to code for primary procedure)
• C8957 – Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump
• C9014 – Injection, cerliponase alfa, 1 mg
• C9015 – Injection, c-1 esterase inhibitor (human), haegarda, 10 units
• C9021 – Injection, obinutuzumab, 10 mg
• C9022 – Injection, elosulfase alfa, 1mg
• C9023 – Injection, testosterone undecanoate, 1 mg
• C9024 – Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
• C9025 – Injection, ramucirumab, 5 mg
• C9026 – Injection, vedolizumab, 1 mg
• C9027 – Injection, pembrolizumab, 1 mg
• C9028 – Injection, inotuzumab ozogamicin, 0.1 mg